Abstract
Advances in machine learning, innovations in imaging hardware, and standardisation of protocols are unfolding the potential of medical imaging as central diagnostic tool for prostate cancer. Beyond the improvement in repeatability, objectivity, and speed that come with automated support, the use of artificial intelligence (AI) opens the way for better diagnostic accuracy by using not only visual features but also a large number of mathematically calculated features that are not obvious to the human eye. Beyond diagnosis, the information provided by those features is relevant also for management of PCa, including prediction of progress, recurrence, and survival. Overall, radiologists have a positive attitude towards the use of AI as support tool, but the impact of AI on PCa assessment in clinical practice has been modest so far. This chapter presents the state of the art and discusses the potential and limitations of the use of AI for MRI-based diagnosis and management of PCa in clinical practice.
| Original language | English |
|---|---|
| Title of host publication | Artifcial Intelligence and Data Analytics in Medical Imaging |
| Editors | Christopher Hayre, Rob Davidson, Shayne Chau, Xiaoming Zheng, Abel Zhou, Nigel Frame |
| Publisher | CRC Press |
| Chapter | 10 |
| Pages | 207-223 |
| Number of pages | 17 |
| Edition | 1 |
| ISBN (Electronic) | 9781040497517 |
| ISBN (Print) | 9781032494913 |
| DOIs | |
| Publication status | Published - 1 Jan 2026 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Artifcial Intelligence for MRI-Based Diagnosis of Prostate Cancer in Clinical Practice'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver